| 摘要 |
PURPOSE: A pharmaceutical composition containing an extract of Actinidia polygama (S. et Z.) Max., pharmaceutically acceptable carriers or excipients is provided. The pharmaceutical composition is free from toxicity and has an excellent lowering effect on blood uric acid levels and can be used in the prevention and treatment of gout disease. CONSTITUTION: The pharmaceutical composition for the prevention and treatment of gout disease contains 0.5 to 50% by weight of an Actinidia polygama extract, pharmaceutically acceptable carriers or excipients. The Actinidia polygama extract is a crude extract which is soluble in water, lower alcohol or a mixed solvent thereof, or an extract which is soluble in a nonpolar solvent. The lower alcohol is ethanol or methanol, the nonpolar solvent is ethyl acetate, chloroform, hexane and ether. The dosage of the pharmaceutical composition is 0.1 to 100mg/kg per day. The health beverage contains 0.01 to 15% by weight of the Actinidia polygama extract.
|
